Moderate

Postoperative nausea & vomiting (PONV) - risk stratification, prophylaxis & rescue

Apfel-based multimodal PONV management · Perioperative & Anaesthesia
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

PONV is common and distressing; risk is stratified by the Apfel score (female sex, non-smoker, history of PONV/motion sickness, postoperative opioids). Prophylaxis uses multiple agents from different classes proportionate to risk, with rescue from a different class to that used prophylactically.

Red flags

  • Protracted vomiting with dehydration/electrolyte disturbance
  • Features suggesting bowel obstruction or surgical complication
  • Headache/neurology suggesting raised ICP
  • Vomiting with reduced consciousness (aspiration risk)
  • Refractory PONV despite multi-class rescue

Assessment

Differential diagnosis

  • Other causes of postoperative vomiting: ileus/bowel obstruction, raised intracranial pressure, hypotension, hypoglycaemia
  • Drug side-effects (opioids, antibiotics)
  • Gastric distension/aspiration
  • Pain-related nausea
  • Metabolic (hyponatraemia, DKA)
  • Pregnancy

Investigations

  • Apfel risk score at pre-assessment (0-4 risk factors)
  • Review surgery type (laparoscopic, gynae, middle-ear, strabismus higher risk)
  • Assess for treatable contributors: hypotension, pain, hypoglycaemia, gastric distension
  • Hydration/electrolyte status if protracted vomiting
  • Exclude surgical/intracranial causes if atypical or severe

Management

  • Stratify risk using the Apfel score and surgical/anaesthetic risk factors
  • Reduce baseline risk: use regional anaesthesia where possible, propofol TIVA, minimise volatiles and nitrous oxide, opioid-sparing multimodal analgesia, and adequate hydration
  • Give prophylaxis proportionate to risk, combining agents from different classes (e.g. dexamethasone at induction + ondansetron at end of surgery)
  • For high-risk patients add a third agent (e.g. droperidol or a scopolamine patch) and favour TIVA
  • Ensure adequate IV fluids and treat hypotension and pain which aggravate PONV
  • For established PONV, give a RESCUE antiemetic from a DIFFERENT class to that used for prophylaxis
  • Avoid simply repeating ondansetron within ~6h if already given prophylactically
  • Correct reversible factors (hypotension, gastric distension, opioid load)
  • Reassess and escalate to combination rescue if refractory
  • Document PONV and effective agents for future anaesthetics

Drugs & doses

Dexamethasone 4-8 mg IV at induction (prophylaxis)
Ondansetron 4 mg IV at end of surgery (prophylaxis or rescue if not previously given)
Droperidol 0.625-1.25 mg IV (prophylaxis/rescue)
Cyclizine 50 mg IV/IM (antihistamine, rescue)
Prochlorperazine 12.5 mg IM
Hyoscine hydrobromide 1 mg transdermal patch
Aprepitant 40 mg PO (NK1 antagonist, high-risk)
Metoclopramide 10 mg IV (limited efficacy; avoid in young for dystonia)
Propofol TIVA as a technique reduces PONV

Disposition

Recovery/ward management with multimodal antiemetics; most resolve, escalate only if protracted vomiting, dehydration or a surgical cause is suspected.

Complications & pitfalls

  • Dehydration and electrolyte imbalance
  • Wound dehiscence and bleeding from retching
  • Aspiration pneumonitis
  • Delayed discharge and unplanned admission
  • Patient dissatisfaction and oesophageal injury (rarely Mallory-Weiss)

Exam pearls

  • Rescue with a DIFFERENT class - repeating the same drug within hours adds little
  • Dexamethasone is best given at induction (delayed onset); ondansetron at the end of surgery
  • TIVA with propofol and avoiding nitrous/volatiles substantially cuts PONV in high-risk patients
  • Droperidol is effective but carries a QT-prolongation caution at higher doses
  • Combination prophylaxis is additive - use multiple classes for Apfel 3-4

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.